Nervgen Pharma Corp

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.20

+0.01 (+0.46%)

As of Jun 21, 10:22 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +467.7% upside

Low Target $8.17

Average Target $12.49

High Target $18.41

Current Price $2.20

Current
$2.20

Target
$12.49

$8.17 $12.49 avg $18.41

Scenario Analysis

Bear Case

$8.17

271.4%

Low target

Base Case

$12.49

+467.7%

Avg target

Bull Case

$18.41

+736.8%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$8.49

-74.1% from high

52-Week Low

$2.71

+-18.8% from low

Target vs 52W High

$12.49

+47.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+19.4%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+24.7%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+31.4%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+40.7%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+214.2%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+168.5%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-34.5%